Navigation Links
GSI to Present at Upcoming Investor Growth Conferences
Date:1/9/2008

BILLERICA, Mass., Jan. 9 /PRNewswire-FirstCall/ -- GSI Group Inc. (Nasdaq: GSIG), a leading manufacturer of laser-based precision motion products and systems, today announced it will be presenting at both the Needham & Company 10th Annual Growth Conference in New York City on January 10th and the Fifth Annual Sidoti & Company Emerging Growth Conference in Palm Beach Florida on January 22nd.

Mr. Robert Bowen, Chief Financial Officer, will be speaking at both events.

About GSI Group Inc.

GSI Group Inc. supplies laser-based precision motion products and systems to the global medical, semiconductor, electronics, and industrial markets. GSI Group Inc.'s common shares are listed on the NASDAQ exchange under the symbol GSIG.

Certain statements in this news release may constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the United States Securities Act of 1933 and Section 21E of the United States Securities Exchange Act of 1934. These forward-looking statements may relate to anticipated financial performance, management's plans and objectives for future operations, business prospects, outcome of regulatory proceedings, market conditions, tax issues and other matters. All statements contained in this news release that do not relate to matters of historical fact should be considered forward-looking statements, and are generally identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "objective" and other similar expressions. Readers should not place undue reliance on the forward- looking statements contained in this news release. Such statements are based on management's beliefs and assumptions and on information currently available to management and are subject to risks, uncertainties and changes in condition, significance, value and effect. Other risks include the fact that the Company's sales have been and are expected to continue to be dependent upon customer capital equipment expenditures, which are, in turn, affected by business cycles in the markets served by those customers. Other factors include volatility in the semiconductor industry, the risk of order delays and cancellations, the risk of delays by customers in introducing their new products and market acceptance of products incorporating subsystems supplied by the Company, risks of currency fluctuations, risks to the Company of delays in its new products, our ability to continue to reduce costs and capital expenditures, our ability to focus R&D investment and integrate acquisitions, changes in applicable accounting standards, tax regulations or other external regulatory rules and standards, and other risks detailed in reports and documents filed by the Company with the United States Securities and Exchange Commission and with securities regulatory authorities in Canada. Such risks, uncertainties and changes in condition, significance, value and effect, many of which are beyond the Company's control, could cause the Company's actual results and other future events to differ materially from those anticipated. The Company does not, however, assume any obligation to update these forward- looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. For more information contact: Investor Relations, 978-439-5511, Ray Ruddy, (ext. 6170)


'/>"/>
SOURCE GSI Group Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
2. Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference
3. Emageon to Present at the 26th Annual JPMorgan Healthcare Conference
4. Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
5. Covance to Present at 26th Annual JPMorgan Healthcare Conference
6. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
7. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
8. DaVita Inc. to Present at JPMorgan Healthcare Conference
9. Hologic to Present at the 26th Annual JP Morgan Healthcare Conference
10. WebMD to Present at Upcoming Investor Conferences
11. Neurochem to present at JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... , ... May 26, 2017 , ... After raising nearly ... Top gadget will continue to be available at a discounted crowdfunding price on ... stress wherever they are, I also wanted to bring a fidget toy to the ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Dr. Alex ... proud to announce a new, informational blog post on insurance options. If a Bay ... insurance plans may help save time and money. Visiting an in-network provider for a ...
(Date:5/26/2017)... ... 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells the stories of ... is the creation of published author, Penelope Colt, mother, trader, horse farmer, artist and a ... when she was three. At six, they moved to Dayton, Ohio, where Penny graduated ...
(Date:5/24/2017)... ... May 24, 2017 , ... In modern research, success depends ... instruments for research and understanding the basic principles that were designed to drive ... innovations in stereo microscopy for brightfield and fluorescence typically used in laboratories working ...
(Date:5/24/2017)... ... May 24, 2017 , ... Drs. ... NY, who have now spent 10 years as clinical instructors for the reputable ... College of Dentistry. Through the program, private practitioners receive cutting-edge clinical training and ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... MACRA replaces the outdated sustainable growth ... reimbursement. Black Book Research crowdsource-surveyed 8,845 physician practices from ... Market for MIPS Compliance Technology is Booming ... 3 or more clinicians seek to buy Merit-Based Incentive ... magnitude of the changes, the hunt is on for ...
(Date:5/4/2017)... May 4, 2017  Fortuna Fix Inc. (" Fortuna ... the first to eliminate the need for embryonic and fetal ... treat neurodegenerative diseases. Fortuna announced today ... Michael Fehlings , MD, PhD; Father Kevin FitzGerald ... MPH; and Professor James Giordano , PhD. ...
(Date:5/4/2017)... 2017  A new tight-tolerance microextrusion medical tubing ... materials, is being launched by Natvar, a Tekni-Plex ... in recent years to service a wide variety ... More expensive materials such as glass and fluoropolymers ... to their ability to consistently hold tolerances. This ...
Breaking Medicine Technology: